Efficacy and safety of intravitreal pegcetacoplan in geographic atrophy: Results from the phase 3 DERBY and OAKS trials

被引：0
|
作者：
Guymer, Robyn H. [1 ]
Mitchell, Paul [2 ]
Wong, James [3 ]
Heier, Jeff [4 ]
Singh, Rishi [5 ]
Steinle, Nathan [6 ]
Boyer, David [7 ]
Mones, Jordie [8 ]
Staurenghi, Giovanni [9 ]
Holz, Frank [10 ]
Bliss, Caleb [11 ]
Deschatelets, Pascal [11 ]
Grossi, Federico [11 ]
Francois, Cedric [11 ]
Wykoff, Charlie [12 ]
Ribeiro, Ramiro [11 ]
机构：
[1] Univ Melbourne, Royal Victorian Eye & Ear Hosp, Ctr Eye Res Australia, Melbourne, Vic, Australia
[2] Sydney West Retina, Sydney, NSW, Australia
[3] Strathfield Retina Clin, Sydney, NSW, Australia
[4] Ophthalm Consultants Boston, Boston, MA USA
[5] Cleveland Clin, Cole Eye Inst, Cleveland, OH 44106 USA
[6] Retina Vitreous Associates Med Grp, Beverly Hills, CA USA
[7] Retina Vitreous Associates Med Grp, Los Angeles, CA USA
[8] Ctr Med Teknon, Barcelona, Spain
[9] Luigi Sacco Hosp, Milan, Italy
[10] Univ Augenklin Bonn, Bonn, Germany
[11] Apellis Pharmaceut, Waltham, MA USA
[12] Retina Consultants Texas, Dallas, TX USA
来源：
CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY | 2022年 / 49卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页码：833 / 833
页数：1
相关论文
共 50 条
  • [31] Alirocumab efficacy and safety by race and ethnicity: Analysis from 3 ODYSSEY phase 3 trials
    Ferdinand, Keith C.
    Jacobson, Terry A.
    Koren, Andrew
    Elassal, Joseph
    Thompson, Desmond
    Deedwania, Prakash
    JOURNAL OF CLINICAL LIPIDOLOGY, 2019, 13 (04) : 586 - 593
  • [32] DIABETES Safety and efficacy of albiglutide - results from two trials
    Derosa, Giuseppe
    Maffioli, Pamela
    NATURE REVIEWS ENDOCRINOLOGY, 2014, 10 (09) : 514 - 516
  • [33] EFFICACY AND SAFETY OF ALIROCUMAB STRATIFIED BY AGE IN PHASE 3 TRIALS
    Raal, Frederick J.
    Tuomilehto, Jaakko
    Lee, L. Veronica
    Louie, Michael
    Minini, Pascal
    Ginsberg, Henry
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (13) : 2005 - 2005
  • [34] Efficacy and Safety of Bempedoic Acid by Sex: Pooled Analyses From Phase 3 Trials
    Goldberg, Anne C.
    Banach, Maciej
    Catapano, Alberico L.
    Duell, P. Barton
    Leiter, Lawrence A.
    Bloedon, LeAnne T.
    Feng, Amy
    Mancini, G.
    CIRCULATION, 2020, 142
  • [35] Efficacy and Safety of Lemborexant in Elderly Subjects with Insomnia: Results of a Pooled Analysis of Two Phase 3 Trials
    Moline, M.
    Yardley, J.
    Pinner, K.
    Kumar, D.
    Bsharat, M.
    Karppa, M.
    Zammit, G.
    Perdomo, C.
    Mianulli, C.
    Rosenberg, R.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2020, 68 : S56 - S56
  • [36] Efficacy and safety of bimekizumab in axial spondyloarthritis: results of two parallel phase 3 randomised controlled trials
    van der Heijde, Desiree
    Deodhar, Atul
    Baraliakos, Xenofon
    Brown, Matthew A.
    Dobashi, Hiroaki
    Dougados, Maxime
    Elewaut, Dirk
    Ellis, Alicia M.
    Fleurinck, Carmen
    Gaffney, Karl
    Gensler, Lianne S.
    Haroon, Nigil
    Magrey, Marina
    Maksymowych, Walter P.
    Marten, Alexander
    Massow, Ute
    Oortgiesen, Marga
    Poddubnyy, Denis
    Rudwaleit, Martin
    Shepherd-Smith, Julie
    Tomita, Tetsuya
    van den Bosch, Filip
    Vaux, Thomas
    Xu, Huji
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 (04) : 515 - 526
  • [37] Safety and efficacy of lasmiditan in patients with cardiovascular risk factors: results from two phase 3 trials for acute treatment of migraine
    Hochstetler, H. M.
    Dennehy, E. B.
    Khanna, R.
    Doty, E. G.
    Berg, P. H.
    Starling, A. J.
    Shapiro, R. E.
    EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 : 67 - 67
  • [38] Efficacy and Safety of Tolebrutinib Versus Teriflunomide in Relapsing Multiple Sclerosis: Results from the Phase 3 GEMINI 1 and 2 Trials
    Oh, Jiwon
    Arnold, Douglas L.
    Cree, Bruce A. C.
    Ionete, Carolina
    Kim, Ho Jin
    Sormani, Maria Pia
    Syed, Sana
    Chen, Yixin
    Maxwell, Christina
    Benoit, Patrick
    Turner, Timothy J.
    Wallstroem, Erik
    Wiendl, Heinz
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 1145 - 1146
  • [39] Efficacy and safety of doravirinebased regimens by sex and race: Long-term results from three phase 3 clinical trials
    Walmsley, S.
    Kumar, P.
    Orkin, C.
    Thompson, M.
    Squires, K.
    Xu, Z. J.
    Greaves, W.
    Plank, R.
    Whiteside, Y.
    Lahoulou, R.
    HIV MEDICINE, 2023, 24 : 669 - 671
  • [40] Niraparib Efficacy and Safety in Patients With BRCA-Mutated Ovarian Cancer: Results From Three Phase 3 Niraparib Trials
    不详
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2021, 19 (08) : 7 - 8
12345